<DOC>
	<DOCNO>NCT01487603</DOCNO>
	<brief_summary>Lung cancer lead cause death world . Overall 5-year survival rate few 10 % effectiveness conventional chemotherapy limit . The new knowledge show correlation genetic alteration effective chemotherapy . Therefore non-surgical modality obtain tumor specimen genetic alteration analysis particularly critical lung cancer , since many patient advanced disease time first presentation , therefore eligible radical surgery . Endobronchial ultrasound-guided transbronchial needle aspiration ( EBUS-TBNA ) sample obtain diagnosis lung cancer use molecular analysis predict response treatment prognosis . In study , detect specific target molecule related effectiveness treatment ( surgery , chemotherapy , radiotherapy ) prognosis patient lung cancer use EBUS-TBNA sample combine xenograft technology .</brief_summary>
	<brief_title>Feasibility Evaluating Gene Alteration Analysis Using Samples Obtained EBUS-TBNA Patients With Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Age 18 year old . Patients confirm suspected lung cancer require EBUSTBNA part stag investigation mediastinum consider trial . Patients undiagnosed enlarged lymph node mediastinum suspicious lung cancer tissue diagnosis require . Patients deem clinical ground medically fit bronchoscopy . Patients high clinical suspicion lymphoma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Patients</keyword>
	<keyword>undiagnosed enlarge</keyword>
	<keyword>lymph node</keyword>
</DOC>